ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
三倍做多标普生物-Direxion
231.99
-11.1000
-4.57%
盘后:
231.21
-0.7800
-0.34%
19:59 EDT
成交量:
29.56万
成交额:
7,010.13万
市值:
6.20亿
市盈率:
- -
高:
244.67
开:
241.52
低:
230.22
收:
243.09
52周最高:
341.93
52周最低:
102.35
股本:
267.45万
流通股本:
267.45万
量比:
0.45
换手率:
11.05%
股息:
0.90
股息率:
0.39%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
美股异动 | 礼来(LLY.US)涨1.69% 阿尔茨海默病血液检测获FDA批准
智通财经
·
09/01
FDA批准替尔泊肽用于降低T2D成人患者心血管事件风险
格隆汇
·
09/01
仙琚制药(002332.SZ):黄体酮阴道片获得美国FDA注册申请受理
智通财经
·
09/01
仙琚制药:100mg黄体酮阴道片ANDA获美国FDA受理
智通财经
·
09/01
百济神州:PD-1抗癌药降价加入美国公共医疗保险计划 今后上市创新药均将执行最惠国定价
每日经济新闻
·
09/01
迪哲医药:舒沃哲新增适应症上市申请获美国FDA受理
智通财经
·
08/30
9月1日起,乌鲁木齐灵活就业人员可参加生育保险 !
新疆949交通广播
·
08/30
美国FDA批准胰腺癌突破性药物 独立药企Revolution Medicines迎里程碑
环球市场播报
·
08/28
中国生物制药(01177.HK):LM-364“NECTIN-4TMEADC”临床试验申请获NMPA及FDA批准
智通财经
·
08/28
美国FDA批准吉利德用于治疗艾滋病的口服药
格隆汇
·
08/28
莫德纳获美国FDA批准,推出2026‑2027版更新新冠疫苗。
智通财经
·
08/28
美国食品药品监督管理局:FDA批准首款用于治疗成人皮肌炎的口服药物。
智通财经
·
08/28
美国 FDA:美敦力召回 2027 年 10 月 20 日前到期的 Bravo CF 相关批次产品。
智通财经
·
08/27
加拿大皇家银行首席执行官在电话会议上表示,市场环境总体上仍保持建设性态势,自然资源、电力基础设施、战略防御、医疗保健及人
智通财经
·
08/27
医疗健康板块市场动态综述
投资观察
·
08/27
FDA批准首个广谱RAS抑制剂Rasonque:二线胰腺癌死亡风险降六成,月费3.98万美元
环球市场播报
·
08/27
人民健康保险铜川分公司被罚9.9万,涉虚挂中介业务套取费用
蓝鲸财经
·
08/27
福建:拟支持海峡两岸生物技术和医疗健康产业合作区建设
格隆汇APP
·
08/27
福建:拟支持海峡两岸生物技术和医疗健康产业合作区建设
智通财经
·
08/27
医疗保健板块市场动态综述
投资观察
·
08/27
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/LABU/news?page=10"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"三倍做多标普生物-Direxion","latestPrice":231.99,"timestamp":1791835200000,"preClose":243.09,"halted":0,"volume":295561,"hourTrading":{"tag":"盘后","latestPrice":231.21,"preClose":231.99,"latestTime":"19:59 EDT","volume":3834,"amount":888365.3656,"timestamp":1791849594803,"change":-0.78,"changeRate":-0.003362,"amplitude":0.007343},"delay":0,"changeRate":-0.04566210045662098,"floatShares":2674486,"shares":2674486,"eps":0,"marketStatus":"未开盘","change":-11.1,"latestTime":"10-12 16:00:00 EDT","open":241.52,"high":244.6716,"low":230.2215,"amount":70101341.22782,"amplitude":0.059443,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791878400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":243.09,"sharesOutstanding":3074486,"nav":242.822,"aum":649423578.22,"dividendRate":0.003877,"bidAskSpread":0.002692,"preHourTrading":{"tag":"盘前","latestPrice":242.43,"preClose":243.09,"latestTime":"09:29 EDT","volume":24862,"amount":6085203.2304,"timestamp":1791811795117,"change":-0.66,"changeRate":-0.002715,"amplitude":0.021844},"postHourTrading":{"tag":"盘后","latestPrice":231.21,"preClose":231.99,"latestTime":"19:59 EDT","volume":3834,"amount":888365.3656,"timestamp":1791849594803,"change":-0.78,"changeRate":-0.003362,"amplitude":0.007343},"volumeRatio":0.453297,"impliedVol":0.9772,"impliedVolPercentile":0.736},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2674486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.453297,"shares":2674486,"dividePrice":0.8994,"high":244.6716,"amplitude":0.059443,"preClose":243.09,"low":230.2215,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":231.99,"eps":0,"divideRate":0.003877,"volume":295561,"delay":0,"ttmEps":0,"open":241.52,"prevYearClose":159.39,"prevWeekClose":243.09,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.38,"twentyDayClose":268.39,"sixtyDayClose":265.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664685079","title":"美股异动 | 礼来(LLY.US)涨1.69% 阿尔茨海默病血液检测获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664685079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664685079?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 23:35","pubTimestamp":1788276923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664481854","title":"FDA批准替尔泊肽用于降低T2D成人患者心血管事件风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2664481854","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664481854?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 21:41","pubTimestamp":1788270068,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385320","title":"仙琚制药(002332.SZ):黄体酮阴道片获得美国FDA注册申请受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385320","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385320?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260459,"startTime":"0","endTime":"0","summary":"智通财经APP讯,仙琚制药(002332.SZ)发布公告,公司向美国食品药品监督管理局(简称“FDA”)递交了黄体酮阴道片的ANDA注册申请,公司于近日收到美国FDA注册申请受理的通知。黄体酮阴道片适应症为辅助生殖ART黄体支持,通过补充黄体功能,支持胚胎着床与早期妊娠。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK0028","002332","LABU","BK4585","SG9999014674.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385362","title":"仙琚制药:100mg黄体酮阴道片ANDA获美国FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385362?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 18:51","pubTimestamp":1788259894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664026884","title":"百济神州:PD-1抗癌药降价加入美国公共医疗保险计划 今后上市创新药均将执行最惠国定价","url":"https://stock-news.laohu8.com/highlight/detail?id=2664026884","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664026884?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 09:36","pubTimestamp":1788226577,"startTime":"0","endTime":"0","summary":"美国当地时间8月31日,美国总统特朗普宣布与9家制药企业达成全新协议,为美国民众下调处方药价格,药价对标其他发达国家的最低采购价,即“最惠国(MFN)价格”,其中包括国内创新药龙头百济神州。9月1日,百济神州对《每日经济新闻》记者表示,根据协议,百济神州将通过Medicaid项目,以约定的价格向符合条件的患者提供替雷利珠单抗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609013861069086.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609013861069086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06160","MEDX","BK4139","LU1719994722.HKD","BK1500","LU1251922891.USD","688235","CANC","06978","LABU","LU1969619763.USD","LU2328871848.SGD","KURE","LNGR","BK4526","LU0307460666.USD","LU1169590202.USD","LU0588546209.SGD","BK0239","XBI","ONC","BK4588","XLV","BK1574","BK4023","LU1303224171.USD","BK1588","LU0228659784.USD","BK1583","IBBQ","LU0828237510.HKD","LU1770034418.SGD","PD","LU1169589451.USD","BK1161","BK4581","IPOS","BK4585","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663776046","title":"迪哲医药:舒沃哲新增适应症上市申请获美国FDA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2663776046","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663776046?lang=zh_cn&edition=fundamental","pubTime":"2026-08-30 15:45","pubTimestamp":1788075936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4588","BK4585","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663462770","title":"9月1日起,乌鲁木齐灵活就业人员可参加生育保险 !","url":"https://stock-news.laohu8.com/highlight/detail?id=2663462770","media":"新疆949交通广播","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663462770?lang=zh_cn&edition=fundamental","pubTime":"2026-08-30 15:09","pubTimestamp":1788073740,"startTime":"0","endTime":"0","summary":"灵活就业人员完成生育保险参保登记后,按照税务部门征管规定按月申报缴纳生育保险费,缴费渠道、征管方式与职工基本医疗保险一致,由税务部门统一征收。待遇保障方面,灵活就业人员连续缴纳职工医保满6个月,即可享受生育医疗费用报销。生育津贴方面,参加生育保险的灵活就业人员生育相关手术发生时,生育保险连续缴费满10个月,可按月申领生育津贴;缴费不足10个月的,缴满10个月后再申领。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-30/doc-iniqaqpr2826938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061828","title":"美国FDA批准胰腺癌突破性药物 独立药企Revolution Medicines迎里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061828","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061828?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 18:15","pubTimestamp":1787912149,"startTime":"0","endTime":"0","summary":"Revolution Medicines历时近十年持续攻关,在500人规模临床试验中获得积极数据,最终获得监管批准。为完成交易,戈德史密斯与Warp Drive最大股东赛诺菲协商,将后者持有的Warp Drive多数股权置换为Revolution Medicines的部分股权,最终达成协议。在正式获批前,美国食品药品管理局已通过同情用药项目允许Revolution Medicines提前约四个月向患者分发药物,截至获批时已有超过2000名患者纳入该项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-28/doc-inipwhrt5845666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["IDNA","IE0009355771.USD","BK4585","IE00B2B36J28.USD","BK4588","LABU","BK4139","IE0009354923.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0889565916.HKD","BBH","IE00BFTCPJ56.SGD","IE0002141913.USD","RVMD","IE00B4R5TH58.HKD","PTH","CANC","IE00BJT1NW94.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662689280","title":"中国生物制药(01177.HK):LM-364“NECTIN-4TMEADC”临床试验申请获NMPA及FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2662689280","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662689280?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 16:52","pubTimestamp":1787907146,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BK4588","LABU","PSYK","IBBJ","MDTX","BK4585","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662805853","title":"美国FDA批准吉利德用于治疗艾滋病的口服药","url":"https://stock-news.laohu8.com/highlight/detail?id=2662805853","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662805853?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 10:37","pubTimestamp":1787884672,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080013","title":"莫德纳获美国FDA批准,推出2026‑2027版更新新冠疫苗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080013?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860702,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662803570","title":"美国食品药品监督管理局:FDA批准首款用于治疗成人皮肌炎的口服药物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662803570","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662803570?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 03:14","pubTimestamp":1787858068,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662089854","title":"美国 FDA:美敦力召回 2027 年 10 月 20 日前到期的 Bravo CF 相关批次产品。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662089854","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662089854?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 22:59","pubTimestamp":1787842744,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662470717","title":"加拿大皇家银行首席执行官在电话会议上表示,市场环境总体上仍保持建设性态势,自然资源、电力基础设施、战略防御、医疗保健及人","url":"https://stock-news.laohu8.com/highlight/detail?id=2662470717","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662470717?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 20:37","pubTimestamp":1787834238,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4130","XPAV","KWH","LABU","VHT","JOUL","VOLT","TRFM","XLV","BLDX","NFRA","TCAI","XBI","CSEN","BK4596","RIFR","BILD","BK4585","NFRX","CSIO","CGVV","BILT","FAN","TEXN","PWRD","NOBL","BK4550","BK4588","BK4581","TPZ","IPAV","MGNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197781007","title":"医疗健康板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1197781007","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197781007?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 16:25","pubTimestamp":1787819101,"startTime":"0","endTime":"0","summary":"此外,诺和诺德的ziltivekimab药物在一项晚期临床试验中未能降低心脏病发作或中风风险后,实际上已退出竞争舞台。这家丹麦制药巨头下月将迎来一场至关重要的资本市场日活动,德意志银行补充道。消息公布后,公司股价下滑1.6%,报300.10丹麦克朗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2238330802.EUR","SG9999003826.SGD","LU1634259557.SGD","LU2506952097.USD","SG9999008742.SGD","SG9999001903.USD","SG9999002562.SGD","LU2506951958.HKD","SG9999004360.SGD","LU0950375773.USD","LU0823397285.USD","IE0003895053.USD","LU0211331839.USD","LU0011963245.USD","LU0588545490.SGD","LU2506951875.HKD","LU0823038988.USD","LU0543330483.HKD","SGXZ43160589.SGD","LU0345775950.USD","SGXZ27511609.SGD","LU0048597586.USD","LU0084288322.USD","LU1634259391.SGD","SG9999002414.USD","BK6516","LU0577902371.SGD","LU0823397103.USD","SG9999003925.USD","SG9999006266.SGD","LU0823413660.USD","IE0031814969.USD","SGXZ91733576.SGD","LU1839390173.USD","LU0577902538.SGD","LABU","LU0188438112.USD","BK4581","SGXZ51708014.SGD","SG9999003800.SGD","LU1497733631.SGD","LU1130305938.SGD","LU0165289439.USD","LU2257852520.SGD","SG9999000343.SGD","D05.SI","LU0251144936.SGD","SGXZ24219693.SGD","LU0831103253.SGD","LU0169518387.USD","LU0630378429.USD","LU2237957902.USD","LU0048573645.USD","LU1282649067.USD","SG9999011175.SGD","LU0441854154.USD","SG9999001135.SGD","LU0261947096.USD","LU0384037296.USD","LU0557290698.USD","SG9999001127.SGD","LU0320764755.SGD","SGXZ70427877.SGD","LU0588545730.USD","BK4585","LU0823417737.USD","LU2506952170.USD","LU0675040207.SGD","SG9999000475.SGD","LU0096374516.USD","LU1282649141.HKD","SG9999004220.SGD","LU0029875118.USD","LU1282649810.SGD","LU1956131251.USD","LU1497733557.USD","IE00BGHQDM52.EUR","SG9999002604.SGD","SG9999002406.SGD","SG9999001846.SGD","LU0955648018.USD","LU0128522157.USD","BK4588","SG9999000459.SGD","LU0488056044.USD","SG9999014302.SGD","LU0345776255.USD","LU0648948544.HKD","LU0823417653.USD","IE00BKZH1Z71.USD","LU0192582467.USD","LU1504937902.USD","LU0865486749.SGD","SG9999014484.SGD","LU0898667661.SGD","LU0205439572.USD","LU0672654166.SGD","LU0878004406.USD","LU0577902454.USD","LU0886674414.USD","LU1522347837.USD","LU0235996351.USD","LU3227948356.SGD","LU0588545904.SGD","BK6523","LU0737861269.HKD","LU0955623706.USD","LU0043850808.USD","LU1770036033.HKD","LU0210637038.USD","LU0878005551.USD","LU0577902298.EUR","LU0532188223.SGD","LU0823413587.USD","LU0882747503.HKD","SG9999013353.USD","SGXZ16066938.SGD","LU0441851309.USD","LU0873338254.USD","SG9999013460.SGD","IE00BVYPNP33.GBP","LU1211504680.USD","LU1497734951.SGD","LU0061477393.USD","LU0261945553.USD","LU2152927971.USD","SG9999013478.USD","SG9999016042.SGD","LU0577902611.USD","BK6112","SG9999002679.SGD","LU2237957811.SGD","LU0326948709.USD","LU1363072403.SGD","SG9999007991.SGD","SG9999001226.SGD","XBI","SG9999013486.USD","LU0823039010.USD","LU0315178854.USD","SG9999002620.SGD","LU0251143029.SGD","LU0831093199.SGD","LU0971096721.USD","SG9999014492.USD","SG9999005177.SGD","SG9999009443.AUD","XLV","SGXZ58947870.SGD","LU0762540952.USD","IE00BVYPNQ40.USD","LU0955669360.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662249779","title":"FDA批准首个广谱RAS抑制剂Rasonque:二线胰腺癌死亡风险降六成,月费3.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662249779","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662249779?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 15:55","pubTimestamp":1787817300,"startTime":"0","endTime":"0","summary":"当地时间8月26日,美国食品药品管理局批准Revolution Medicines公司的口服药Rasonque,用于已接受至少一线全身治疗、或不适合多药联合全身治疗的成年转移性胰腺腺癌患者。这是该适应证下首个获批的广谱RAS抑制剂。批发采购成本为每30天39800美元。公司称RAS G12突变人群方向一致。同管道的另一款RAS抑制剂zoldonrasib已在6月进入与化疗联合用于RAS G12D转移性胰腺癌一线的III期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-27/doc-iniptxkt5340944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775745","title":"人民健康保险铜川分公司被罚9.9万,涉虚挂中介业务套取费用","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775745","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775745?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 14:56","pubTimestamp":1787813815,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月27日讯,近日,铜川金融监管分局发布行政处罚决定书,剑指中国人民健康保险股份有限公司铜川分公司及相关责任人。罚单显示,中国人民健康保险股份有限公司铜川分公司的主要违法违规行为是:利用保险代理人虚挂中介业务套取费用。针对上述违法行为,铜川金融监管分局对中国人民健康保险股份有限公司铜川分公司罚款9.9万元;对宋鹏飞给予警告并处罚款1.1万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787810487255386596","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["XLV","LABU","BK4581","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775292","title":"福建:拟支持海峡两岸生物技术和医疗健康产业合作区建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775292","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775292?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 14:49","pubTimestamp":1787813340,"startTime":"0","endTime":"0","summary":"格隆汇8月27日丨今日,《福建省“十五五”卫生健康发展规划》印发。其中提到,深化卫生健康两岸融合发展,构建跨区域开放发展新格局。加强两岸医疗健康产业合作,推动闽台在生物医药研发、重大疾病防控、前沿医疗技术研究等领域交流合作。支持海峡两岸生物技术和医疗健康产业合作区建设。深化闽台医药融合,鼓励引进台湾地区已上市的高临床价值创新药械在本省医疗机构应用。支持福建中医药大学建设闽台融合中医药重点实验室。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-08-27/doc-inipttav9117970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4550","BK4585","IXJ","BK4588","HELX","LABU","WDNA","BK4581","XLV","159760","VHT","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662077593","title":"福建:拟支持海峡两岸生物技术和医疗健康产业合作区建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2662077593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662077593?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 14:45","pubTimestamp":1787813117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","VHT","WDNA","XLV","IXJ","BK4585","BK4550","LABU","XBI","HELX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171038950","title":"医疗保健板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1171038950","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171038950?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 04:53","pubTimestamp":1787777585,"startTime":"0","endTime":"0","summary":"医疗保健领域最新市场快讯,涵盖了多家重要企业的动态与分析师观点。伯恩斯坦研究指出,依视路陆逊梯卡旗下核心品牌雷朋可能因其智能眼镜产品线引发的隐私担忧而遭受长期声誉损害。杰富瑞分析师在一份研究报告中表示,基础医疗控股的长期增长轨迹受到医疗保健使用率上升及其他利好因素的支撑。其门诊设施使其能够从医院护理向门诊护理转移的趋势中获益。杰富瑞首次覆盖该股,给予买入评级,目标价为1.10新加坡元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","XBI","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}